NCT01430182

Brief Summary

The purpose of this study is to determine whether, for surgery of the tibia, one dose of methadone provides better control of pain afterward as compared to morphine, which is the usual drug given to control pain after surgery. Immediately after the beginning of general anesthesia ("intraoperatively"), subjects will receive one dose of either methadone or morphine, in the amount of 0.2 milligrams per kilogram of body weight, intravenously. The primary hypothesis is that, subjects who receive one dose of methadone intraoperatively will require less pain medicine than subjects who receive one dose of morphine intraoperatively.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

September 6, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 8, 2011

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

April 4, 2016

Completed
Last Updated

April 4, 2016

Status Verified

March 1, 2016

Enrollment Period

2.8 years

First QC Date

September 6, 2011

Results QC Date

March 3, 2016

Last Update Submit

March 3, 2016

Conditions

Keywords

AdultFemaleHumansIntraoperative Care/methodsMaleMethadone/administration & dosageAnalgesics/therapeutic useMethadone/therapeutic useMorphine/therapeutic useMiddle AgedPain Measurement/drug effectsPain Measurement/methodsPain, Postoperative/prevention & controlProspective StudiesDouble-Blind MethodTibial Fractures/surgeryYoung AdultOrthopedics

Outcome Measures

Primary Outcomes (1)

  • Opioid Consumption

    Number of morphine equivalents used by subject during first 24 hours after discharge from Post-Anesthesia Care Unit

    First 24 hours after discharge from Post-Anesthesia Care Unit

Study Arms (2)

Methadone 0.2 mg/kg

EXPERIMENTAL

0.2 mg/kg methadone by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete.

Drug: Methadone

Morphine 0.2 mg/kg

ACTIVE COMPARATOR

0.2 mg/kg morphine by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete.

Drug: Morphine

Interventions

0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.

Also known as: Bioniche Pharma, METHADONE HYDROCHLORIDE INJECTION
Methadone 0.2 mg/kg

0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.

Also known as: Morphine sulfate
Morphine 0.2 mg/kg

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects scheduled for elective, non-emergent intramedullary nailing (IMN) or open reduction/internal fixation (ORIF) of the tibia at Ben Taub General Hospital
  • Able to give consent (not cognitively impaired or intoxicated)
  • Subjects must be 18-50 years of age
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Scheduled for primary intramedullary nailing or open reduction/internal fixation of fractures of the tibial shaft or proximal tibia. This must be the first operation for this injured extremity.
  • Associated fractures of the fibula will be allowed.
  • Minor lacerations or other associated injuries like "road rash" or open wounds requiring skin graft are permitted

You may not qualify if:

  • Subjects who have taken preoperative opioids for more than 7 days before surgery (i.e., tolerant)
  • Regular use of opioids (whether recreational/illicit or prescribed) within the six months before injury
  • Subjects who are recommended to receive a regional nerve block or a neuraxial technique (spinal or epidural) by the attending orthopedic surgeon
  • Subjects who refuse general anesthesia
  • Subjects deemed to be moderately or severely hypovolemic
  • External fixator already in place on the injured extremity
  • Presence of other moderate-to-severe or distracting injuries, such as orthopedic, cervical spine, neurological, intra-abdominal, or intra-thoracic injuries. Minor abrasions/lacerations such as "road rash" or open wounds are acceptable. Associated fibular injuries are acceptable. Small peripheral injuries such as a finger or toe requiring percutaneous pinning are acceptable. Small skin grafts (no more than 100 cm\^2) are permitted
  • Pregnancy or breastfeeding (verify urine pregnancy test)
  • Associated or pre-existing head injury or Traumatic Brain Injury
  • Difficulty or inability to understand the study or the protocol
  • Severe obesity (BMI \> 36.0 kg/m\^2)
  • Known respiratory or cardiovascular problems, such as obstructive sleep apnea, or oxygen saturation of less than 96% on room air
  • Acute bronchial asthma
  • Chronic renal failure (serum creatinine \> 2.0 mg/dL)
  • Liver failure (defined as history of cirrhosis or fulminant hepatic failure)
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ben Taub General Hospital

Houston, Texas, 77030, United States

Location

Related Publications (5)

  • Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24.

    PMID: 20418538BACKGROUND
  • Gourlay GK, Willis RJ, Lamberty J. A double-blind comparison of the efficacy of methadone and morphine in postoperative pain control. Anesthesiology. 1986 Mar;64(3):322-7. doi: 10.1097/00000542-198603000-00004.

    PMID: 3954126BACKGROUND
  • Gourlay GK, Willis RJ, Wilson PR. Postoperative pain control with methadone: influence of supplementary methadone doses and blood concentration--response relationships. Anesthesiology. 1984 Jul;61(1):19-26.

    PMID: 6742480BACKGROUND
  • Gourlay GK, Wilson PR, Glynn CJ. Pharmacodynamics and pharmacokinetics of methadone during the perioperative period. Anesthesiology. 1982 Dec;57(6):458-67. doi: 10.1097/00000542-198212000-00005. No abstract available.

    PMID: 6128949BACKGROUND
  • Gourlay GK, Wilson PR, Glynn CJ. Methadone produces prolonged postoperative analgesia. Br Med J (Clin Res Ed). 1982 Feb 27;284(6316):630-1. doi: 10.1136/bmj.284.6316.630. No abstract available.

    PMID: 6802264BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativePainTibial Fractures

Interventions

MethadoneMorphine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsFractures, BoneWounds and InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

KetonesOrganic ChemicalsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Limitations and Caveats

Early termination leading to small numbers of subjects analyzed. Shortages of IV methadone prompted closure of trial.

Results Point of Contact

Title
Neil Bailard
Organization
Baylor College of Medicine

Study Officials

  • Neil S Bailard, MD

    Dept. of Anesthesiology, Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Anesthesiology

Study Record Dates

First Submitted

September 6, 2011

First Posted

September 8, 2011

Study Start

September 1, 2011

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

April 4, 2016

Results First Posted

April 4, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will not share

Locations